Takeda Pharmaceutical (TAK) Income from Continuing Operations (2017 - 2026)
Takeda Pharmaceutical's Income from Continuing Operations came in at $1.33 billion for the quarter ended Jun 30, 2026, up 8.8% from $1.22 billion a year earlier but down 1.6% from the prior quarter.
Takeda Pharmaceutical (TAK) Income from Continuing Operations (2017 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Takeda Pharmaceutical reported Income from Continuing Operations of $1.94 billion, down 49.6% year-over-year; for the year ended Mar 31, 2026, it was -$880.79 million.
- Going back by year, Income from Continuing Operations was $1.59 billion in the year ended Mar 31, 2025, -$267.76 million in the year ended Mar 31, 2024, $3.21 billion in the year ended Mar 31, 2023 (-4.0%) and $3.34 billion in the year ended Mar 31, 2022 (-0.6%).
- The five-year range for quarterly Income from Continuing Operations is -$3.52 billion (the quarter ended Dec 31, 2025) to $2.78 billion (the quarter ended Sep 30, 2025).
- The fastest year-over-year change in Income from Continuing Operations over five years came in the quarter ended Sep 30, 2023 (growth of 297.9%), and the weakest in the quarter ended Dec 31, 2023 (a decline of 97.3%).
- Business Quant data shows TAK's Income from Continuing Operations at $1.35 billion (quarter ended Mar 31, 2026), -$3.52 billion (quarter ended Dec 31, 2025) and $2.78 billion (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.28 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 3.09 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -246.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Takeda Pharmaceutical | 2.63 Bn | -23.88 Bn | 5.10 Bn | 1.33 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.33 Bn |
| Mar 31, 2026 | 1.35 Bn |
| Dec 31, 2025 | -3.52 Bn |
| Sep 30, 2025 | 2.78 Bn |
| Jun 30, 2025 | 1.22 Bn |
| Mar 31, 2025 | 1.26 Bn |
| Dec 31, 2024 | -998.51 Mn |
| Sep 30, 2024 | 2.37 Bn |
| Jun 30, 2024 | 1.14 Bn |
| Mar 31, 2024 | 1.23 Bn |
| Dec 31, 2023 | 23.00 Mn |
| Sep 30, 2023 | 1.94 Bn |
| Jun 30, 2023 | 1.32 Bn |
| Mar 31, 2023 | 1.56 Bn |
| Dec 31, 2022 | 843.22 Mn |
| Sep 30, 2022 | 487.77 Mn |
| Jun 30, 2022 | 1.59 Bn |
| Mar 31, 2022 | 2.65 Bn |
| Jun 30, 2021 | 2.82 Bn |
| Mar 31, 2021 | 1.89 Bn |
Takeda Pharmaceutical Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();